B cell depletion therapy upregulates Dkk-1 skin expression in patients with systemic sclerosis: association with enhanced resolution of skin fibrosis

BACKGROUND: Rituximab (RTX) may favorably affect skin and lung fibrosis in patients with systemic sclerosis (SSc); however, the underlying molecular mechanisms remain unknown. We aimed to explore the hypothesis that RTX may mediate its antifibrotic effects by regulating the expression of Dickkopf-1...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Arthritis Res Ther
Glavni autori: Daoussis, Dimitrios, Tsamandas, Athanassios, Antonopoulos, Ioannis, Filippopoulou, Alexandra, Papachristou, Dionysios J., Papachristou, Nicholaos I., Andonopoulos, Andrew P., Liossis, Stamatis-Nick
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4875588/
https://ncbi.nlm.nih.gov/pubmed/27208972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-1017-y
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items